In vivo metabolism of 5-methoxy-N,N-diisopropyltryptamine in rat

Journal of Health Science

Volumn 52, Issue 4, 2006, Pages 425-430

  Kanamori, Tatsuyuki ^a   Kuwayama, Kenji ^a   Tsujikawa, Kenji ^a   Miyaguchi, Hajime ^a   Iwata, Yuko ^a   Inoue, Hiroyuki ^a   Kishi, Tohru ^a  

^a NATIONAL RESEARCH INSTITUTE OF POLICE SCIENCE   (Japan)

Author keywords

5 methoxy N,N diisopropyltryptamine; Metabolism; Quantitation; Rat; Urine

Indexed keywords

5 HYDROXY N ISOPROPYLTRYPTAMINE; 5 HYDROXY N,N DIISOPROPYLTRYPTAMINE; 5 METHOXY N ISOPROPYLTRYPTAMINE; 5 METHOXYINDOLEACETIC ACID; DRUG METABOLITE; N,N DIISOPROPYL 5 METHOXYTRYPTAMINE; PSYCHOTROPIC AGENT; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; DRUG STRUCTURE; DRUG URINE LEVEL; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; IN VIVO STUDY; KIDNEY CLEARANCE; LIQUID LIQUID EXTRACTION; MALE; MASS SPECTROMETRY; NONHUMAN; QUANTITATIVE ANALYSIS; RAT;

RATTUS NORVEGICUS;

EID: 33746852478     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.52.425     Document Type: Article

References (7)

1. Shulgin, A. T. and Carter, M. F. (1980) N,N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), two orally active tryptamine analogs with CNS activity. Common. Psychopharmacol., 4, 363-369.
2. Meatherall, R. and Sharma, P. (2003) Foxy, a designer tryptamine hallucinogen. J. Anal. Toxicol., 27, 313-317.
3. Wilson, J. M., McGeorge, F., Smolinske, S. and Meatherall, R. (2005) A foxy intoxication. Forensic Sci. Int., 148, 31-36.
4. Kamata, T., Katagi, M., Kamata, H. T., Miki, A., Shima, N., Zaitsu, K., Nishikawa, M., Tanaka, E., Honda, K. and Tsuchihashi, H. (2006) Metabolism of psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) in humans. Identification and quantification of urinary metabolites. Drug Metab. Dispos., 34, 281-287.
5. Shulgin, A. and Shulgin, A. (1997) TiHKAL, Tryptamines I have Known and Loved, Transform Press, Berkeley, CA.
6. Sanders-Bush, E. and Mayer S. E. (2006) 5-Hydroxytryptamine (Serotonin): Receptor Agonists and Antagonists. In Goodman & Gilman's the pharmacological basis of therapeutics, 11th ed. (Brunton, L. L., Lazo, J. S. and Parker, K. L., Eds.), The McGraw-Hill companies, New York, pp. 297-299.
7. Narimatsu, S., Yonemoto, R., Saito, K., Takaya, K., Kumamoto, T., Ishikawa, T., Asanuma, M., Funada, M., Kiryu, K., Naito, S., Yoshida, Y., Yamamoto, S. and Hanioka, N. (2006) Oxidative metabolism of 5-methoxy-N,N- diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes. Biochem. Pharmacol., 71, 1377-1385.